Epidemiology of bone tumors in Lebanon: a retrospective study from 2000 to 2022 at a tertiary center.

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Future Science OA Pub Date : 2023-08-08 eCollection Date: 2023-10-01 DOI:10.2144/fsoa-2023-0102

Mohammad Daher, Ziad Zalaquett, Elio Mekhael, Marven Aoun, Ralph Chalhoub, Majd Abdo, Marc Aoude, Sami Abi Farraj, Ali Ghoul, Jean Tarchichi, Joe Rassi, Amer Sebaaly, Viviane Trak-Smayra, Carole Kesrouani, Hampig-Raphaël Kourie, Ismat Ghanem

{"title":"Epidemiology of bone tumors in Lebanon: a retrospective study from 2000 to 2022 at a tertiary center.","authors":"Mohammad Daher, Ziad Zalaquett, Elio Mekhael, Marven Aoun, Ralph Chalhoub, Majd Abdo, Marc Aoude, Sami Abi Farraj, Ali Ghoul, Jean Tarchichi, Joe Rassi, Amer Sebaaly, Viviane Trak-Smayra, Carole Kesrouani, Hampig-Raphaël Kourie, Ismat Ghanem","doi":"10.2144/fsoa-2023-0102","DOIUrl":null,"url":null,"abstract":"Aim: Bone tumors are rare and have an uneven geographic distribution.Methods: 730 patients diagnosed with bone tumors were included in this retrospective analysis.Results: With a 64% rate of malignancy, the most common tumors were metastasis (40%) mostly in the axial skeleton, Osteosarcoma (9%) mostly in the femur, Osteochondroma (8%) mostly in the femur, giant cell tumors (7%) mostly in the knee, and Ewing's sarcoma (6%) mostly in the axial skeleton.Conclusion: Even though a some of the tumors have a predilection for certain localizations in the human body, they may differ in the middle-eastern population. One must also pay attention to the higher rates of malignancies as compared with other cohorts.","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 9","pages":"FSO886"},"PeriodicalIF":2.4000,"publicationDate":"2023-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518824/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2144/fsoa-2023-0102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 1

Abstract

Aim: Bone tumors are rare and have an uneven geographic distribution.

Methods: 730 patients diagnosed with bone tumors were included in this retrospective analysis.

Results: With a 64% rate of malignancy, the most common tumors were metastasis (40%) mostly in the axial skeleton, Osteosarcoma (9%) mostly in the femur, Osteochondroma (8%) mostly in the femur, giant cell tumors (7%) mostly in the knee, and Ewing's sarcoma (6%) mostly in the axial skeleton.

Conclusion: Even though a some of the tumors have a predilection for certain localizations in the human body, they may differ in the middle-eastern population. One must also pay attention to the higher rates of malignancies as compared with other cohorts.

Abstract Image

查看原文本刊更多论文

黎巴嫩骨肿瘤流行病学：一项2000年至2022年在三级中心进行的回顾性研究。

目的：骨肿瘤是罕见的，并且具有不均匀的地理分布。方法：对730例诊断为骨肿瘤的患者进行回顾性分析。结果：恶性肿瘤的发生率为64%，最常见的肿瘤是转移瘤（40%），主要发生在轴骨，骨肉瘤（9%），骨软骨瘤（8%），骨巨细胞瘤（7%），尤因肉瘤（6%），主要出现在轴骨。结论：尽管某些肿瘤在人体内有某些定位的偏好，但它们在中东部人群中可能有所不同。人们还必须注意，与其他人群相比，恶性肿瘤的发病率更高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

5.00

自引率

4.00%

发文量

审稿时长

13 weeks

期刊介绍： Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries